₹5651.9▲2.93%
3.18%
Low
Day's Volatility:4.27%
High
1.08%
44.71%
Low
52 Weeks Volatility:72.47%
High
27.76%
Returns % | |
1 Month Return | + 3.9 % |
3 Month Return | -0.22 % |
1 Year Return | + 67.21 % |
Market Stats | |
Previous Close | ₹₹5,491.20 |
Open | ₹₹5,509.00 |
Volume | ₹17.92K |
Upper Circuit | ₹- |
Lower Circuit | ₹- |
Market Cap | ₹₹13,728.00Cr |
Organisation | Astrazeneca Pharma India Ltd |
Headquarters | Bangalore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Astrazeneca Pharma India Ltd
Despite earnings growth tracking behind five-year shareholder returns, AstraZeneca Pharma India's EPS grew at an impressive rate of 24% per year over the past five years. The stock has gained 18% in share price over the same period, indicating a more cautious market sentiment towards the stock. However, with a P/E ratio of 97.19, the market remains optimistic. The company rewarded shareholders with a total return of 71% in the last twelve months, including dividends.
AstraZeneca Pharma India Sees Increase in Volume and Revenue Growth - 04 Apr, 2024
AstraZeneca Pharma India reports significant annual EPS and revenue growth, while insiders hold shares worth ₹10b. The company also sees a surge in trading volume on the NSE.
AstraZeneca Receives Approval for New Indications of Trastuzumab Deruxtecan - 29 Mar, 2024
AstraZeneca Pharma India has received approval from the CDSCO to import and distribute Trastuzumab deruxtecan lyophilized powder for concentrate for solution for infusion 100mg for HER2-low metastatic breast cancer and HER2 positive gastric/gastro-oesophageal cancer.
Fundamentals of Astrazeneca Pharma India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
FII Holding Up
Foreign Institutions have increased holdings from 2.65% to 2.74% in Mar 2024 quarter
Price Rise
In the last 7 days, ASTRAZEN stock has moved up by 7.0%
MF Holding Up
Mutual Funds have increased holdings from 2.75% to 3.75% in Mar 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 122.3% return, outperforming this stock by 78.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 75.00% of holdings in Mar 2024 quarter
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 93.2% return, outperforming this stock by 26.0%
Retail Holding Down
Retail Investor have decreased holdings from 19.57% to 18.48% in Mar 2024 quarter
Investors | Holdings % | Prev. 1 periods | 3M change |
---|---|---|---|
Promoter Holdings | 75% | 0.00 | |
Foreign Institutions | 2.74% | 0.00 | |
Mutual Funds | 3.75% | 0.00 | |
Retail Investors | 18.48% | 0.00 | |
Others | 0.04% | 0.00 |
Technicals of Astrazeneca Pharma India Ltd share
News & Events of Astrazeneca Pharma India Ltd
Astrazeneca Pharma India Ltd (ASTRAZEN) share price today is ₹5651.9
Astrazeneca Pharma India Ltd is listed on NSE
Astrazeneca Pharma India Ltd is listed on BSE
Today’s traded volume of Astrazeneca Pharma India Ltd(ASTRAZEN) is 17.92K.
Today’s market capitalisation of Astrazeneca Pharma India Ltd(ASTRAZEN) is ₹13728Cr.
Astrazeneca Pharma India Ltd(ASTRAZEN | Price |
---|---|
52 Week High | ₹7220.95 |
52 Week Low | ₹3125 |
Astrazeneca Pharma India Ltd(ASTRAZEN) share price is ₹5651.9. It is down -21.73% from its 52 Week High price of ₹7220.95
Astrazeneca Pharma India Ltd(ASTRAZEN) share price is ₹5651.9. It is up 80.86% from its 52 Week Low price of ₹3125
Astrazeneca Pharma India Ltd(ASTRAZEN | Returns |
---|---|
1 Day Returns | 160.7% |
1 Month Returns | 3.9% |
3 Month Returns | -0.22% |
1 Year Returns | 67.21% |